NCT05559619

Brief Summary

Sixty-eight postmenopausal women diagnosed with osteoporosis aged between 50 and 60 years were randomly allocated to one of two equal sets. The drug treatment group received calcium and vitamin D3 supplement daily for 12 weeks. While the drug/laser acupuncture group received laser acupuncture therapy for 20 minutes per session 3 times weekly, in addition to the same calcium and vitamin D3 supplement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 11, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
Last Updated

February 12, 2024

Status Verified

February 1, 2024

Enrollment Period

11 months

First QC Date

September 26, 2022

Last Update Submit

February 9, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Bone mineral density

    T-score of Forearm bone mineral density that was evaluated by dual energy X-ray absorptiometry

    12 weeks after theray

  • Pain Visual analogue score

    It is a 10-cm horizontal line on which a mark between the extremes of "no pain at all" and "worst agony conceivable" was used to reflect the patient's level of discomfort.

    12 weeks after theray

Study Arms (2)

Drug treatment group

ACTIVE COMPARATOR

34 postmenopausal women who only received oral calcium and vitamin D3 supplement (Calcium D3F® (Arab Company for Pharmaceutical\& medicinal plants (MEPACO-MEDIFOOD, EGPYT). Each tablet contains 1000 mg of natural calcium carbonate, 1000 IU vitamin D3 (0.025 mg) and 0.25 mg Sodium Fluoride. They received 1 tablet once daily for 12 weeks

Drug: Calcium carbonateDrug: Vitamin D3

Drug treatment + laser acupuncture group

ACTIVE COMPARATOR

34 postmenopausal women who received laser acupuncture therapy in addition to the same calcium and vitamin D3 supplement for 12 weeks.

Drug: Calcium carbonateDrug: Vitamin D3Device: laser acupuncture therapy

Interventions

1000 mg of natural calcium carbonate once daily for 12 weeks

Also known as: Calcium D3F
Drug treatment + laser acupuncture groupDrug treatment group

1000 IU vitamin D3 once daily for 12 weeks

Also known as: Calcium D3F
Drug treatment + laser acupuncture groupDrug treatment group

The patient was in crock lying for stimulation of acupoints in abdomen and lower limbs then asked to be in side lying for stimulation of acupoints in the back. After disinfection of the skin and careful localization of the acupoints, low level laser therapy (LLLT) (model: Lis 1050, SN: EM 13481014, manufactured by EME srl, Italy) was applied bilaterally on Dazhu (BL 11), Ganshu(BL 18), Pishu (BL20), Shenshu (BL23), Zusanli (ST 36), Sanyinjiao (Sp6), Jingmen(GB25), Yanglingquan (GB34) andXuanzhong (GB39) acupoints, while it was applied in the midline on Guanyuan (CV4) andMingmen (GV4) acupoints. Each acupoint was irradiated for 60 sec, with total duration of 20 min, wave length of 905 nm, average radiant power output of 12 mW, energy density of 2 J/cm2, pulse radiation of 200 ms and pulse frequency of 5000 Hz

Drug treatment + laser acupuncture group

Eligibility Criteria

Age50 Years - 60 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • age between 50 and 60 years
  • body mass index (BMI) between 25 and 35 Kg/m2.
  • Multiparas with a parity of 5 or more were included.
  • They had decreased forearm BMD with T score of DEXA less than or equal to -2.5 wrist pain with visual analogue scale (VAS) ≥ 3
  • natural menopause for at least four years

You may not qualify if:

  • history of bone disease, renal, liver, endocrinal or parathyroid disorders, cardiac affection,
  • using a pacemaker
  • taking any drugs which may affect bone metabolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alainy medical school

Cairo, 12111, Egypt

Location

Related Publications (1)

  • Hassan ES, Maged AM, Kotb A, Fouad M, El-Nassery N, Kamal WM. Effect of laser acupuncture on pain and density of bone in osteoporotic postmenopausal women: a randomized controlled trial. Menopause. 2023 May 1;30(5):545-550. doi: 10.1097/GME.0000000000002166. Epub 2023 Mar 20.

MeSH Terms

Conditions

Osteoporosis, Postmenopausal

Interventions

Calcium CarbonateCholecalciferol

Condition Hierarchy (Ancestors)

OsteoporosisBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Calcium CompoundsInorganic ChemicalsCarbonatesCarbonic AcidCarbon Compounds, InorganicMineralsCholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Ahmed M Maged

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

September 26, 2022

First Posted

September 29, 2022

Study Start

July 11, 2021

Primary Completion

June 5, 2022

Study Completion

August 6, 2022

Last Updated

February 12, 2024

Record last verified: 2024-02

Locations